You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Merck
Mallinckrodt
Boehringer Ingelheim
Baxter

Last Updated: June 5, 2020

DrugPatentWatch Database Preview

Wyeth Ayerst Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for WYETH AYERST, and what generic and branded alternatives to WYETH AYERST drugs are available?

WYETH AYERST has eighty-two approved drugs.



Summary for Wyeth Ayerst
US Patents:0
Tradenames:64
Ingredients:56
NDAs:82

Drugs and US Patents for Wyeth Ayerst

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst PENBRITIN ampicillin/ampicillin trihydrate CAPSULE;ORAL 060908-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Wyeth Ayerst PATHOCIL dicloxacillin sodium CAPSULE;ORAL 050011-003 Mar 28, 1983 DISCN No No   Start Trial   Start Trial
Wyeth Ayerst ROBITET tetracycline hydrochloride CAPSULE;ORAL 061734-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Wyeth Ayerst DIMENHYDRINATE dimenhydrinate INJECTABLE;INJECTION 084316-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Wyeth Ayerst

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Ayerst INDERAL propranolol hydrochloride SUSPENSION;ORAL 019536-001 Dec 12, 1986 4,600,708   Start Trial
Wyeth Ayerst PEPTAVLON pentagastrin INJECTABLE;INJECTION 017048-001 Approved Prior to Jan 1, 1982 3,896,103   Start Trial
Wyeth Ayerst INDERIDE LA 120/50 hydrochlorothiazide; propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 019059-002 Jul 3, 1985 4,138,475   Start Trial
Wyeth Ayerst INDERIDE LA 80/50 hydrochlorothiazide; propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 019059-001 Jul 3, 1985 4,138,475   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Baxter
Express Scripts
Colorcon
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.